Press release
Enterobacteriaceae Infection Drug: A Guide to Understanding the Process
Enterobacteriaceae Infection Drug Market
Enterobacteriaceae are a large family of different types of germs (bacteria) that commonly cause infections in healthcare settings. Examples of germs in the Enterobacteriaceae family include Escherichia coli (E. coli) and Klebsiella pneumoniae.
MARKET DYNAMICS
Rising prevalence of Enterobacteriaceae infectious diseases, For instance, in 2021, CRE caused an estimated 13,100 infections in hospitalized patients, and 1,100 estimated deaths in the United States increasing modes of spread of the infectious disease and a lack of cleanliness are the driving factors. However, the major factor which will restrain the market growth rapid resistance to drugs currently available for enterobacter infections. Furthermore, launch of new antibiotics with activity against carbapenem-resistant Enterobacteriaceae (CRE) will offer lucrative opportunities in the market.
Get More Details with Sample PDF Copy @ https://www.theinsightpartners.com/sample/TIPRE00008464?utm_source=OpenPR&utm_medium=10852
Enterobacteriaceae Infection Drug Market: Competitive Landscape and Key Developments:
1. Genentech, Inc.
2. Allergan
3. Novartis AG
4. Pfizer Inc.
5. Nymox Pharmaceutical Corporation
6. Sequoia Sciences, Inc.
7. Phico Therapeutics Ltd.
8. Melinta Therapeutics, Inc.
9. Spero Therapeutics
10. Cipla USA, Inc.
Contact Us:
If you have any queries about this report or if you would like further information, please contact us:
Contact Person: Ankit Mathur
E-mail: sales@theinsightpartners.com
Phone: +1-646-491-9876
About Us:
The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We specialize in industries such as Semiconductor and Electronics, Aerospace and Defense, Automotive and Transportation, Biotechnology, Healthcare IT, Manufacturing and Construction, Medical Device, Technology, Media and Telecommunications, Chemicals and Materials.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Enterobacteriaceae Infection Drug: A Guide to Understanding the Process here
News-ID: 3870165 • Views: …
More Releases from The Insight Partners
Global Electronic Data Interchange (EDI) Market Set to Reach US$ 74.36 Billion b …
The global Electronic Data Interchange (EDI) market is projected to grow from US$ 34.02 billion in 2024 to US$ 74.36 billion by 2031, registering a robust CAGR of 11.9% during 2025-2031, according to the latest market analysis. The integration of EDI solutions with blockchain technology, increasing digitalization, and growing compliance requirements across industries are expected to bring significant advancements to the market over the next decade.
Download Sample PDF: https://www.theinsightpartners.com/sample/TIPRE00006160/?utm_source=OpenPR&utm_medium=10759
Strong Market…
Biocomposites Market to Grow at a CAGR of 16% to US$ 46,851.39 million in 2028
The biocomposites market is expected to grow from US$ 19,268.62 million in 2022 to US$ 46,851.39 million by 2028; it is estimated to grow at a CAGR of 16% from 2022 to 2028.
Biocomposites are materials formed by reinforcement of natural fibers and matrix (resin). The interest in biocomposites is rapidly growing among end use industries as applications in fundamental research, packaging, construction, military applications, aerospace, railway coaches, and automobiles due…
Coffee Syrup Market: Global Industry Trends, Share, Size, Growth, Opportunity an …
Coffee syrup is a rich, sweet, and aromatic concentrate crafted from brewed coffee and sugar, designed to add bold flavor to a variety of beverages and desserts. Known for its smooth texture and deep coffee essence, it blends effortlessly into milk, iced coffee, cocktails, and baked goods. Whether drizzled over pancakes or stirred into a latte, coffee syrup delivers a delicious burst of energy and warmth. Popular in both home…
Advancing Healthcare: Implantable Sensor Market Expected to Quadruple by 2031
As healthcare continues to embrace technological innovation, Implantable Sensor Market are revolutionizing patient monitoring and treatment management worldwide. These tiny yet powerful devices are transforming the way medical conditions are diagnosed, tracked, and treated, offering continuous real-time data that enhances clinical decisions and patient outcomes.
Check valuable insights in the Implantable Sensor Market report. You can easily get a sample PDF of the report - https://www.theinsightpartners.com/sample/TIPRE00016982?utm_source=OpenPr&utm_medium=10457
In a rapidly evolving landscape, the…
More Releases for Enterobacteriaceae
Carbapenem-Resistant Enterobacteriaceae (CRE) Infection Market is expected to re …
Carbapenem-resistant Enterobacteriaceae (CRE) represent one of the most dangerous groups of multidrug-resistant (MDR) bacteria, including Klebsiella pneumoniae and Escherichia coli. These pathogens are resistant to nearly all available antibiotics, including carbapenems, which are considered last-resort treatments.
Download Full PDF Sample Copy of Market Report @ https://exactitudeconsultancy.com/request-sample/71765
CRE infections are associated with high mortality rates (up to 50%), prolonged hospital stays, and major economic burden. They occur most often in hospitalized, immunocompromised, and…
Global Carbapenem-Resistant Enterobacteriaceae (CRE) Testing Market to Reach USD …
The global Carbapenem-resistant Enterobacteriaceae (CRE) testing market is experiencing significant growth, driven by the escalating prevalence of CRE infections and the imperative need for rapid, The global carbapenem-resistant enterobacteriaceae testing market is estimated at a value of US$ 4.25 billion in 2024 and is forecasted to reach a size of US$ 8.89 billion by 2034-end. Worldwide demand is projected to advance at a 7.7% CAGR from 2024 to 2034.
Market Development
The…
Enterobacteriaceae Infection Drug Market Trends, Research, Analysis & Forecast 2 …
The latest Enterobacteriaceae Infection Drug Market study offers an all-inclusive analysis of the major strategies, corporate models, and market shares of the most noticeable players in this market. The study offers a thoroughanalysis of the key persuading factors, market figures in terms of revenues, segmental data, regional data, and country-wise data. This study can be described as most wide-ranging documentation that comprises all the aspects of the evolving Enterobacteriaceae Infection…
Enterobacteriaceae Infection Drug Market Size, Share, Development by 2024
LP INFORMATION offers a latest published report on Enterobacteriaceae Infection Drug Market Analysis and Forecast 2019-2025 delivering key insights and providing a competitive advantage to clients through a detailed report.
According to this study, over the next five years the Enterobacteriaceae Infection Drug market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2024, from US$ xx million in 2019.…
Carbapenem-resistant Enterobacteriaceae Testing Market to Partake Significant De …
Enterobacteriaceae are a family of germs that most commonly live in a person’s bowel without causing any disease. Carbapenems are strong antibiotics that are commonly used to treat serious infections. A few enterobacteriaceaea have gained resistance to these antibiotics. These are called Carbapenem-resistant Enterobacteriaceae. Carbapenem-resistant Enterobacteriaceae testing is considered to be a gram-negative pathogen testing. Common gram-negative pathogens include Pseudomonas aeruginosa, Escherichia coli, Klebsiella pneumonia, Enterobacter aerogenes and Acinetobacterbaumannii. These…
Carbapenem-resistant Enterobacteriaceae Testing Market Analysis, Segments, Growt …
Enterobacteriaceae are a family of germs that most commonly live in a person’s bowel without causing any disease. Carbapenems are strong antibiotics that are commonly used to treat serious infections. A few enterobacteriaceaea have gained resistance to these antibiotics. These are called Carbapenem-resistant Enterobacteriaceae. Carbapenem-resistant Enterobacteriaceae testing is considered to be a gram-negative pathogen testing. Common gram-negative pathogens include Pseudomonas aeruginosa, Escherichia coli, Klebsiella pneumonia, Enterobacter aerogenes and Acinetobacterbaumannii.
These gram-negative…
